| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate |
2009-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79ab7b3dd89cb32e3741698ebe711238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0419dbc86d944018d495ba90d264b99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e699247c9f023480844cf79a6866367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6428c8b33a4c64582e86ce126e00765b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ed80e6391b121c2bee08390dbe0985 |
| publicationDate |
2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EC-SP099225-A |
| titleOfInvention |
GLUCAGON RECEIVER ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING THESE COMPOUNDS AND USE PROCEDURES |
| abstract |
Glucagon receptor antagonist compounds are described. The compounds are useful for treating type 2 diabetes and related pathological conditions. Also included are pharmaceutical compositions and treatment procedures. |
| priorityDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |